PNC FINANCIAL SERVICES GROUP, INC. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 162 filers reported holding CARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5,926
-84.0%
1,207
-64.9%
0.00%
Q4 2022$36,946
+15.5%
3,440
-0.4%
0.00%
Q3 2022$32,000
+33.3%
3,455
+31.7%
0.00%
Q2 2022$24,000
+20.0%
2,623
+63.1%
0.00%
Q1 2022$20,000
-13.0%
1,608
-11.6%
0.00%
Q4 2021$23,000
-55.8%
1,820
-44.9%
0.00%
Q3 2021$52,000
+116.7%
3,302
+94.3%
0.00%
Q2 2021$24,000
+1100.0%
1,699
+1707.4%
0.00%
Q1 2021$2,000
+100.0%
940.0%0.00%
Q4 2020$1,000
-75.0%
94
-68.0%
0.00%
Q3 2020$4,000
-20.0%
2940.0%0.00%
Q2 2020$5,000
+25.0%
2940.0%0.00%
Q1 2020$4,000
-80.0%
294
-76.0%
0.00%
Q4 2019$20,000
-9.1%
1,2250.0%0.00%
Q3 2019$22,000
-50.0%
1,225
-40.2%
0.00%
Q2 2019$44,000
+22.2%
2,050
+13.9%
0.00%
Q1 2019$36,000
+56.5%
1,8000.0%0.00%
Q4 2018$23,000
-46.5%
1,8000.0%0.00%
Q3 2018$43,000
-12.2%
1,800
-30.8%
0.00%
Q2 2018$49,000
-12.5%
2,600
-43.5%
0.00%
Q1 2018$56,0000.0%4,6000.0%0.00%
Q4 2017$56,000
-12.5%
4,6000.0%0.00%
Q3 2017$64,000
-8.6%
4,6000.0%0.00%
Q2 2017$70,000
+6.1%
4,600
+27.8%
0.00%
Q1 2017$66,000
+3200.0%
3,600
+1340.0%
0.00%
Q4 2016$2,0002500.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 622,140$10,489,00045.13%
RHO CAPITAL PARTNERS INC 2,668,057$44,983,00015.47%
Opaleye Management Inc. 427,000$7,199,0003.01%
DAFNA Capital Management LLC 169,331$2,855,0002.54%
Private Capital Advisors, Inc. 246,850$4,162,0001.80%
WALL STREET ASSOCIATES 192,300$3,242,0000.91%
SECTORAL ASSET MANAGEMENT INC 1,212,578$20,444,0000.87%
Virtus ETF Advisers LLC 17,299$292,0000.80%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 618,140$10,422,0000.58%
SPHERA FUNDS MANAGEMENT LTD. 197,820$3,335,0000.49%
View complete list of CARA THERAPEUTICS INC shareholders